Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
about
Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?Current pharmacological management of hypotensive syndromes in the elderly.Droxidopa in neurogenic orthostatic hypotension.Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.Distinct neurohumoral biomarker profiles in children with hemodynamically defined orthostatic intolerance may predict treatment options.Orthostatic hypotension: pathophysiology, assessment, treatment and the paradox of supine hypertension.New Horizons in orthostatic hypotension.The Treatment of Primary Orthostatic Hypotension.Orthostatic hypotension: managing a difficult problem.Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders.The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.Is Mania the Hypertension of the Mood? Discussion of A Hypothesis.Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report.Multiple system atrophy: using clinical pharmacology to reveal pathophysiology.Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms.Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
P2860
Q31080551-1BC68846-ABDA-43B6-A2BA-FD23F7C84A8CQ33165704-E3AC4C49-242E-456C-AB34-F75BAFCC02E9Q33165878-E89CCC3C-CEEE-4222-9F7E-01808E281DCAQ33166368-929465C8-833D-4D95-BCF0-00F1D18FE29BQ33166491-A2C65C4C-7DFB-4369-BDE0-906212CE72EDQ33167390-7E54A1DA-71C7-45F1-95F2-53D9D8F59FBFQ33167922-0B16C2FB-D1A2-4F4A-B24A-BB1C1C426D3AQ33168147-7489DFCA-F73B-4B7E-913C-CCB7538D645AQ36943826-BF824725-584E-4BA7-91AD-6DEF4A6721B3Q38823627-69B9ECD7-F1AF-430C-BCBD-262A83ABAADBQ39052115-D029777B-C01A-485E-96D5-7E84AC0069DBQ39305705-266136AF-F777-401B-A10D-645121C4418DQ39438327-548419A3-31D6-4D3D-BA67-355A02328C1DQ40501280-CEB30E1C-1DFC-4948-B4B4-EEA913E85A25Q40660177-254C4243-E9E2-4991-82D1-49D2639DF242Q44746489-60A9C344-DD58-4086-B421-C677669428FBQ48117806-B5AB1A55-A37B-4B00-A1A7-032E7624D7E1Q52672547-D7651B04-B7C1-4674-9B59-0E6B002BC426
P2860
Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@ast
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@en
type
label
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@ast
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@en
prefLabel
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@ast
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@en
P2093
P2860
P1433
P1476
Efficacy of atomoxetine versus ...... otension in autonomic failure.
@en
P2093
Alfredo Gamboa
Amy C Arnold
André Diedrich
Claudia E Ramirez
Cyndya A Shibao
David Robertson
Italo Biaggioni
Leena Choi
Luis E Okamoto
Satish R Raj
P2860
P304
P356
10.1161/HYPERTENSIONAHA.114.04225
P407
P577
2014-09-02T00:00:00Z